Apex, NC, United States of America

Charles G Peele

This inventor holds 7 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Biolex Therapeutics, Inc., Biolex, Inc., Synthon Biopharmaceuticals B.v.. Active years: 2009-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charles G Peele. Retrieved from https://idiyas.com/inventor/charles-g-peele

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 


 

Average Co-Inventor Count = 3.9

ph-index = 2

Forward Citations = 31(Granted Patents)


Company Filing History:


Years Active: 2009-2014

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Charles G Peele: Innovator in Plant Biotechnology

Introduction

Charles G Peele, an accomplished inventor based in Apex, North Carolina, has made significant contributions to the field of plant biotechnology. With an impressive portfolio of seven patents, his work primarily focuses on enhancing the N-glycosylation patterns of proteins in plants, paving the way for advancements in agricultural biotechnology and protein engineering.

Latest Patents

Among his latest patents, one crucial innovation is centered around "Compositions and methods for inhibition of fucosyltransferase and xylosyltransferase expression in plants." This patent outlines methods for altering the N-glycosylation pattern of proteins in higher plants by introducing recombinant RNAi constructs that inhibit the expression of α1,3-fucosyltransferase and β1,2-xylosyltransferase. The innovations enable the production of proteins with humanized N-glycosylation patterns, which are essential for developing therapeutic glycoproteins without affecting plant growth negatively.

Another significant patent covers "Compositions and methods for regulating expression of nucleotide sequences of interest in a plant." This encompasses novel nucleic acid molecules for expression control elements isolated from ubiquitin, r-histone, and chitinase genes. This innovative method enhances the expression of nucleotide sequences of interest, particularly in duckweed, and includes a unique signal peptide-encoding sequence to facilitate the extracellular secretion of polypeptides.

Career Highlights

Charles G Peele has a noteworthy career trajectory, having worked with prominent companies in the biotechnology sector such as Biolex Therapeutics, Inc. and Biolex, Inc. These experiences have allowed him to refine his expertise in plant molecular biology and biotechnological applications, further shaping his innovative contributions.

Collaborations

Throughout his career, Charles has collaborated with esteemed colleagues such as Lynn F Dickey and Kevin Cox, contributing to a dynamic exchange of ideas and research that has propelled his innovations forward. These collaborations highlight the importance of teamwork in fostering advancements in biotechnology.

Conclusion

In summary, Charles G Peele stands out as a significant figure in the field of plant biotechnology, with a robust portfolio of patents that reflect his innovative spirit and commitment to enhancing plant science. His work not only advances the understanding of glycosylation in plants but also opens new avenues for developing therapeutic proteins, marking him as a key contributor to the future of agricultural advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…